TABLE 1.

RE-AIM framework

RE-AIM	Outcome measure	Methods of data collection
REACH	Representativeness of participants recruited to parent research study compared to the general population	Demographic information Comparison of public and private
EFFECTIVENESS	Lymphedema progression rates	Review study audit records
	Can routine and regularly planned monitoring assessment appointments be achieved?	Monitoring assessments completed
	Hospital staff perception on the efficacy of early intervention	Discussions with members of breast cancer multidisciplinary teams and organisational leaders
	Impact on quality of life	LSID-A and FACT-B questionnaire
ADOPTION	Factors contributing to the integration and barriers preventing implementation of the PSM within the public and private health systems	Discussions with organisational leaders identifying concerns prior to, during and post parent research study
	Examining hospitals who did and did not integrate the PSM	Assessing public and private uptake
IMPLEMENTATION	How, by whom and when was the PSM implemented.	Education of clinical staff, planning and monitoring and referral flow
	How was the study modified over time to facilitate implementation	Observations during implementation to address barriers in real time
	Educating patients to become active participants in their monitoring and early intervention	Participants contacting research staff due to swelling concerns
MAINTENANCE	Participant adherence/retention over 3year study time	Research study assessments completed and missed
	Perceptions of maintaining a PSM	Discussions with multidisciplinary team members